nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—Lisinopril—systemic scleroderma	0.0715	0.272	CbGbCtD
Flurazepam—ABCB1—Captopril—systemic scleroderma	0.0535	0.203	CbGbCtD
Flurazepam—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0421	0.16	CbGbCtD
Flurazepam—ABCB1—Prednisone—systemic scleroderma	0.0337	0.128	CbGbCtD
Flurazepam—Lucanthone—TOP1—systemic scleroderma	0.0279	1	CrCbGaD
Flurazepam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0252	0.0959	CbGbCtD
Flurazepam—CYP3A4—Prednisone—systemic scleroderma	0.0202	0.0767	CbGbCtD
Flurazepam—ABCB1—Methotrexate—systemic scleroderma	0.0169	0.0642	CbGbCtD
Flurazepam—Shock—Captopril—systemic scleroderma	0.0024	0.00339	CcSEcCtD
Flurazepam—Leukopenia—Azathioprine—systemic scleroderma	0.00234	0.00329	CcSEcCtD
Flurazepam—Anorexia—Captopril—systemic scleroderma	0.00233	0.00328	CcSEcCtD
Flurazepam—Vision blurred—Leflunomide—systemic scleroderma	0.00232	0.00328	CcSEcCtD
Flurazepam—Asthenia—Pentoxifylline—systemic scleroderma	0.00231	0.00326	CcSEcCtD
Flurazepam—Tension—Mycophenolic acid—systemic scleroderma	0.00231	0.00325	CcSEcCtD
Flurazepam—Nervousness—Mycophenolic acid—systemic scleroderma	0.00228	0.00322	CcSEcCtD
Flurazepam—Hypotension—Captopril—systemic scleroderma	0.00228	0.00322	CcSEcCtD
Flurazepam—Pruritus—Pentoxifylline—systemic scleroderma	0.00228	0.00321	CcSEcCtD
Flurazepam—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00321	CcSEcCtD
Flurazepam—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00227	0.0032	CcSEcCtD
Flurazepam—Flushing—Lisinopril—systemic scleroderma	0.00226	0.00318	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00222	0.00314	CcSEcCtD
Flurazepam—Arthralgia—Azathioprine—systemic scleroderma	0.00222	0.00313	CcSEcCtD
Flurazepam—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00222	0.00312	CcSEcCtD
Flurazepam—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00312	CcSEcCtD
Flurazepam—Leukopenia—Leflunomide—systemic scleroderma	0.00221	0.00311	CcSEcCtD
Flurazepam—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0022	0.00311	CcSEcCtD
Flurazepam—Coma—Methotrexate—systemic scleroderma	0.0022	0.0031	CcSEcCtD
Flurazepam—Palpitations—Leflunomide—systemic scleroderma	0.00218	0.00307	CcSEcCtD
Flurazepam—Dyspnoea—Captopril—systemic scleroderma	0.00218	0.00307	CcSEcCtD
Flurazepam—Somnolence—Captopril—systemic scleroderma	0.00217	0.00306	CcSEcCtD
Flurazepam—Agitation—Mycophenolic acid—systemic scleroderma	0.00216	0.00305	CcSEcCtD
Flurazepam—Dyspepsia—Captopril—systemic scleroderma	0.00215	0.00303	CcSEcCtD
Flurazepam—Lethargy—Prednisone—systemic scleroderma	0.00213	0.00301	CcSEcCtD
Flurazepam—Dizziness—Pentoxifylline—systemic scleroderma	0.00213	0.003	CcSEcCtD
Flurazepam—Decreased appetite—Captopril—systemic scleroderma	0.00212	0.00299	CcSEcCtD
Flurazepam—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00299	CcSEcCtD
Flurazepam—Syncope—Mycophenolic acid—systemic scleroderma	0.00211	0.00297	CcSEcCtD
Flurazepam—Leukopenia—Mycophenolic acid—systemic scleroderma	0.0021	0.00297	CcSEcCtD
Flurazepam—Arthralgia—Leflunomide—systemic scleroderma	0.0021	0.00296	CcSEcCtD
Flurazepam—Chest pain—Leflunomide—systemic scleroderma	0.0021	0.00296	CcSEcCtD
Flurazepam—Anxiety—Leflunomide—systemic scleroderma	0.00209	0.00295	CcSEcCtD
Flurazepam—Constipation—Captopril—systemic scleroderma	0.00209	0.00294	CcSEcCtD
Flurazepam—Tension—Lisinopril—systemic scleroderma	0.00208	0.00293	CcSEcCtD
Flurazepam—Palpitations—Mycophenolic acid—systemic scleroderma	0.00208	0.00293	CcSEcCtD
Flurazepam—Dysgeusia—Lisinopril—systemic scleroderma	0.00207	0.00292	CcSEcCtD
Flurazepam—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00207	0.00291	CcSEcCtD
Flurazepam—Nervousness—Lisinopril—systemic scleroderma	0.00206	0.0029	CcSEcCtD
Flurazepam—Dry mouth—Leflunomide—systemic scleroderma	0.00205	0.00289	CcSEcCtD
Flurazepam—Vomiting—Pentoxifylline—systemic scleroderma	0.00205	0.00289	CcSEcCtD
Flurazepam—Rash—Pentoxifylline—systemic scleroderma	0.00203	0.00286	CcSEcCtD
Flurazepam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00203	0.00286	CcSEcCtD
Flurazepam—Headache—Pentoxifylline—systemic scleroderma	0.00202	0.00284	CcSEcCtD
Flurazepam—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00201	0.00284	CcSEcCtD
Flurazepam—Feeling abnormal—Captopril—systemic scleroderma	0.00201	0.00284	CcSEcCtD
Flurazepam—Arthralgia—Mycophenolic acid—systemic scleroderma	0.002	0.00282	CcSEcCtD
Flurazepam—Chest pain—Mycophenolic acid—systemic scleroderma	0.002	0.00282	CcSEcCtD
Flurazepam—Vision blurred—Lisinopril—systemic scleroderma	0.002	0.00281	CcSEcCtD
Flurazepam—Gastrointestinal pain—Captopril—systemic scleroderma	0.002	0.00281	CcSEcCtD
Flurazepam—Anxiety—Mycophenolic acid—systemic scleroderma	0.00199	0.00281	CcSEcCtD
Flurazepam—Asthenia—Mometasone—systemic scleroderma	0.00199	0.00281	CcSEcCtD
Flurazepam—Irritability—Prednisone—systemic scleroderma	0.00199	0.00281	CcSEcCtD
Flurazepam—Hypotension—Azathioprine—systemic scleroderma	0.00199	0.00281	CcSEcCtD
Flurazepam—Pruritus—Mometasone—systemic scleroderma	0.00197	0.00277	CcSEcCtD
Flurazepam—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00196	0.00276	CcSEcCtD
Flurazepam—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00194	0.00274	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00194	0.00274	CcSEcCtD
Flurazepam—Confusional state—Mycophenolic acid—systemic scleroderma	0.00193	0.00273	CcSEcCtD
Flurazepam—Anorexia—Leflunomide—systemic scleroderma	0.00192	0.0027	CcSEcCtD
Flurazepam—Nausea—Pentoxifylline—systemic scleroderma	0.00191	0.0027	CcSEcCtD
Flurazepam—Diarrhoea—Mometasone—systemic scleroderma	0.0019	0.00268	CcSEcCtD
Flurazepam—Syncope—Lisinopril—systemic scleroderma	0.0019	0.00268	CcSEcCtD
Flurazepam—Leukopenia—Lisinopril—systemic scleroderma	0.0019	0.00267	CcSEcCtD
Flurazepam—Shock—Mycophenolic acid—systemic scleroderma	0.00189	0.00266	CcSEcCtD
Flurazepam—Hypotension—Leflunomide—systemic scleroderma	0.00188	0.00265	CcSEcCtD
Flurazepam—Palpitations—Lisinopril—systemic scleroderma	0.00187	0.00264	CcSEcCtD
Flurazepam—Loss of consciousness—Lisinopril—systemic scleroderma	0.00186	0.00262	CcSEcCtD
Flurazepam—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00185	0.00262	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00183	0.00258	CcSEcCtD
Flurazepam—Anorexia—Mycophenolic acid—systemic scleroderma	0.00183	0.00258	CcSEcCtD
Flurazepam—Tension—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00257	CcSEcCtD
Flurazepam—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00256	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.0018	0.00254	CcSEcCtD
Flurazepam—Chest pain—Lisinopril—systemic scleroderma	0.0018	0.00254	CcSEcCtD
Flurazepam—Arthralgia—Lisinopril—systemic scleroderma	0.0018	0.00254	CcSEcCtD
Flurazepam—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.0018	0.00254	CcSEcCtD
Flurazepam—Anxiety—Lisinopril—systemic scleroderma	0.0018	0.00253	CcSEcCtD
Flurazepam—Dyspnoea—Leflunomide—systemic scleroderma	0.00179	0.00253	CcSEcCtD
Flurazepam—Hypotension—Mycophenolic acid—systemic scleroderma	0.00179	0.00253	CcSEcCtD
Flurazepam—Lethargy—Methotrexate—systemic scleroderma	0.00178	0.00251	CcSEcCtD
Flurazepam—Dyspepsia—Leflunomide—systemic scleroderma	0.00177	0.0025	CcSEcCtD
Flurazepam—Vomiting—Mometasone—systemic scleroderma	0.00177	0.00249	CcSEcCtD
Flurazepam—Dry mouth—Lisinopril—systemic scleroderma	0.00176	0.00249	CcSEcCtD
Flurazepam—Feeling abnormal—Azathioprine—systemic scleroderma	0.00175	0.00248	CcSEcCtD
Flurazepam—Rash—Mometasone—systemic scleroderma	0.00175	0.00247	CcSEcCtD
Flurazepam—Asthenia—Captopril—systemic scleroderma	0.00175	0.00247	CcSEcCtD
Flurazepam—Dermatitis—Mometasone—systemic scleroderma	0.00175	0.00247	CcSEcCtD
Flurazepam—Decreased appetite—Leflunomide—systemic scleroderma	0.00175	0.00247	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00175	0.00247	CcSEcCtD
Flurazepam—Confusional state—Lisinopril—systemic scleroderma	0.00174	0.00246	CcSEcCtD
Flurazepam—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00174	0.00246	CcSEcCtD
Flurazepam—Headache—Mometasone—systemic scleroderma	0.00174	0.00245	CcSEcCtD
Flurazepam—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00173	0.00244	CcSEcCtD
Flurazepam—Pruritus—Captopril—systemic scleroderma	0.00173	0.00243	CcSEcCtD
Flurazepam—Constipation—Leflunomide—systemic scleroderma	0.00172	0.00243	CcSEcCtD
Flurazepam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00171	0.00241	CcSEcCtD
Flurazepam—Somnolence—Mycophenolic acid—systemic scleroderma	0.00171	0.00241	CcSEcCtD
Flurazepam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0024	CcSEcCtD
Flurazepam—Shock—Lisinopril—systemic scleroderma	0.0017	0.0024	CcSEcCtD
Flurazepam—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00169	0.00238	CcSEcCtD
Flurazepam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00167	0.00236	CcSEcCtD
Flurazepam—Diarrhoea—Captopril—systemic scleroderma	0.00167	0.00235	CcSEcCtD
Flurazepam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00167	0.00235	CcSEcCtD
Flurazepam—Irritability—Methotrexate—systemic scleroderma	0.00167	0.00235	CcSEcCtD
Flurazepam—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00235	CcSEcCtD
Flurazepam—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00234	CcSEcCtD
Flurazepam—Feeling abnormal—Leflunomide—systemic scleroderma	0.00166	0.00234	CcSEcCtD
Flurazepam—Nausea—Mometasone—systemic scleroderma	0.00165	0.00233	CcSEcCtD
Flurazepam—Anorexia—Lisinopril—systemic scleroderma	0.00165	0.00232	CcSEcCtD
Flurazepam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00164	0.00232	CcSEcCtD
Flurazepam—Ataxia—Methotrexate—systemic scleroderma	0.00164	0.00231	CcSEcCtD
Flurazepam—Constipation—Mycophenolic acid—systemic scleroderma	0.00164	0.00231	CcSEcCtD
Flurazepam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00231	CcSEcCtD
Flurazepam—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00163	0.0023	CcSEcCtD
Flurazepam—Hypotension—Lisinopril—systemic scleroderma	0.00161	0.00228	CcSEcCtD
Flurazepam—Dizziness—Captopril—systemic scleroderma	0.00161	0.00228	CcSEcCtD
Flurazepam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00158	0.00223	CcSEcCtD
Flurazepam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00223	CcSEcCtD
Flurazepam—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00223	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00157	0.00222	CcSEcCtD
Flurazepam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00222	CcSEcCtD
Flurazepam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00157	0.00221	CcSEcCtD
Flurazepam—Vomiting—Captopril—systemic scleroderma	0.00155	0.00219	CcSEcCtD
Flurazepam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00218	CcSEcCtD
Flurazepam—Dyspnoea—Lisinopril—systemic scleroderma	0.00154	0.00217	CcSEcCtD
Flurazepam—Rash—Captopril—systemic scleroderma	0.00154	0.00217	CcSEcCtD
Flurazepam—Dermatitis—Captopril—systemic scleroderma	0.00154	0.00217	CcSEcCtD
Flurazepam—Somnolence—Lisinopril—systemic scleroderma	0.00154	0.00217	CcSEcCtD
Flurazepam—Headache—Captopril—systemic scleroderma	0.00153	0.00216	CcSEcCtD
Flurazepam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00215	CcSEcCtD
Flurazepam—Dyspepsia—Lisinopril—systemic scleroderma	0.00152	0.00215	CcSEcCtD
Flurazepam—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00214	CcSEcCtD
Flurazepam—Decreased appetite—Lisinopril—systemic scleroderma	0.0015	0.00212	CcSEcCtD
Flurazepam—Shock—Mycophenolate mofetil—systemic scleroderma	0.00149	0.0021	CcSEcCtD
Flurazepam—Constipation—Lisinopril—systemic scleroderma	0.00148	0.00208	CcSEcCtD
Flurazepam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00206	CcSEcCtD
Flurazepam—Diarrhoea—Azathioprine—systemic scleroderma	0.00146	0.00206	CcSEcCtD
Flurazepam—Nausea—Captopril—systemic scleroderma	0.00145	0.00204	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00145	0.00204	CcSEcCtD
Flurazepam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00204	CcSEcCtD
Flurazepam—Asthenia—Leflunomide—systemic scleroderma	0.00144	0.00204	CcSEcCtD
Flurazepam—Hallucination—Prednisone—systemic scleroderma	0.00144	0.00203	CcSEcCtD
Flurazepam—Feeling abnormal—Lisinopril—systemic scleroderma	0.00142	0.00201	CcSEcCtD
Flurazepam—Pruritus—Leflunomide—systemic scleroderma	0.00142	0.00201	CcSEcCtD
Flurazepam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00141	0.002	CcSEcCtD
Flurazepam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00141	0.00199	CcSEcCtD
Flurazepam—Dizziness—Azathioprine—systemic scleroderma	0.00141	0.00199	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00195	CcSEcCtD
Flurazepam—Asthenia—Mycophenolic acid—systemic scleroderma	0.00138	0.00194	CcSEcCtD
Flurazepam—Diarrhoea—Leflunomide—systemic scleroderma	0.00138	0.00194	CcSEcCtD
Flurazepam—Pruritus—Mycophenolic acid—systemic scleroderma	0.00136	0.00191	CcSEcCtD
Flurazepam—Vomiting—Azathioprine—systemic scleroderma	0.00135	0.00191	CcSEcCtD
Flurazepam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00135	0.0019	CcSEcCtD
Flurazepam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00135	0.0019	CcSEcCtD
Flurazepam—Drowsiness—Methotrexate—systemic scleroderma	0.00134	0.0019	CcSEcCtD
Flurazepam—Rash—Azathioprine—systemic scleroderma	0.00134	0.00189	CcSEcCtD
Flurazepam—Dermatitis—Azathioprine—systemic scleroderma	0.00134	0.00189	CcSEcCtD
Flurazepam—Flushing—Prednisone—systemic scleroderma	0.00134	0.00189	CcSEcCtD
Flurazepam—Headache—Azathioprine—systemic scleroderma	0.00133	0.00188	CcSEcCtD
Flurazepam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00188	CcSEcCtD
Flurazepam—Dizziness—Leflunomide—systemic scleroderma	0.00133	0.00188	CcSEcCtD
Flurazepam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00186	CcSEcCtD
Flurazepam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00131	0.00185	CcSEcCtD
Flurazepam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00183	CcSEcCtD
Flurazepam—Sweating—Methotrexate—systemic scleroderma	0.00129	0.00182	CcSEcCtD
Flurazepam—Vomiting—Leflunomide—systemic scleroderma	0.00128	0.0018	CcSEcCtD
Flurazepam—Dizziness—Mycophenolic acid—systemic scleroderma	0.00127	0.00179	CcSEcCtD
Flurazepam—Rash—Leflunomide—systemic scleroderma	0.00127	0.00179	CcSEcCtD
Flurazepam—Dermatitis—Leflunomide—systemic scleroderma	0.00127	0.00179	CcSEcCtD
Flurazepam—Nausea—Azathioprine—systemic scleroderma	0.00126	0.00178	CcSEcCtD
Flurazepam—Headache—Leflunomide—systemic scleroderma	0.00126	0.00178	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—systemic scleroderma	0.00125	0.00177	CcSEcCtD
Flurazepam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00176	CcSEcCtD
Flurazepam—Asthenia—Lisinopril—systemic scleroderma	0.00124	0.00175	CcSEcCtD
Flurazepam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00175	CcSEcCtD
Flurazepam—Pruritus—Lisinopril—systemic scleroderma	0.00122	0.00172	CcSEcCtD
Flurazepam—Vomiting—Mycophenolic acid—systemic scleroderma	0.00122	0.00172	CcSEcCtD
Flurazepam—Rash—Mycophenolic acid—systemic scleroderma	0.00121	0.00171	CcSEcCtD
Flurazepam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00121	0.0017	CcSEcCtD
Flurazepam—Headache—Mycophenolic acid—systemic scleroderma	0.0012	0.0017	CcSEcCtD
Flurazepam—Nausea—Leflunomide—systemic scleroderma	0.00119	0.00168	CcSEcCtD
Flurazepam—Vision blurred—Prednisone—systemic scleroderma	0.00118	0.00167	CcSEcCtD
Flurazepam—Diarrhoea—Lisinopril—systemic scleroderma	0.00118	0.00167	CcSEcCtD
Flurazepam—Agitation—Prednisone—systemic scleroderma	0.00116	0.00163	CcSEcCtD
Flurazepam—Dizziness—Lisinopril—systemic scleroderma	0.00114	0.00161	CcSEcCtD
Flurazepam—Nausea—Mycophenolic acid—systemic scleroderma	0.00114	0.00161	CcSEcCtD
Flurazepam—Syncope—Prednisone—systemic scleroderma	0.00113	0.00159	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisone—systemic scleroderma	0.00111	0.00156	CcSEcCtD
Flurazepam—Vomiting—Lisinopril—systemic scleroderma	0.0011	0.00155	CcSEcCtD
Flurazepam—Rash—Lisinopril—systemic scleroderma	0.00109	0.00154	CcSEcCtD
Flurazepam—Dermatitis—Lisinopril—systemic scleroderma	0.00109	0.00154	CcSEcCtD
Flurazepam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00153	CcSEcCtD
Flurazepam—Headache—Lisinopril—systemic scleroderma	0.00108	0.00153	CcSEcCtD
Flurazepam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00151	CcSEcCtD
Flurazepam—Arthralgia—Prednisone—systemic scleroderma	0.00107	0.00151	CcSEcCtD
Flurazepam—Anxiety—Prednisone—systemic scleroderma	0.00107	0.0015	CcSEcCtD
Flurazepam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00146	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—systemic scleroderma	0.00103	0.00145	CcSEcCtD
Flurazepam—Nausea—Lisinopril—systemic scleroderma	0.00103	0.00145	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisone—systemic scleroderma	0.00103	0.00145	CcSEcCtD
Flurazepam—Shock—Prednisone—systemic scleroderma	0.00101	0.00142	CcSEcCtD
Flurazepam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.001	0.00141	CcSEcCtD
Flurazepam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000992	0.0014	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—systemic scleroderma	0.00099	0.0014	CcSEcCtD
Flurazepam—Anorexia—Prednisone—systemic scleroderma	0.000978	0.00138	CcSEcCtD
Flurazepam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00136	CcSEcCtD
Flurazepam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000955	0.00135	CcSEcCtD
Flurazepam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000954	0.00135	CcSEcCtD
Flurazepam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000948	0.00134	CcSEcCtD
Flurazepam—Leukopenia—Methotrexate—systemic scleroderma	0.000941	0.00133	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000935	0.00132	CcSEcCtD
Flurazepam—Dyspepsia—Prednisone—systemic scleroderma	0.000903	0.00127	CcSEcCtD
Flurazepam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000899	0.00127	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—systemic scleroderma	0.000895	0.00126	CcSEcCtD
Flurazepam—Chest pain—Methotrexate—systemic scleroderma	0.000895	0.00126	CcSEcCtD
Flurazepam—Decreased appetite—Prednisone—systemic scleroderma	0.000892	0.00126	CcSEcCtD
Flurazepam—Constipation—Prednisone—systemic scleroderma	0.000878	0.00124	CcSEcCtD
Flurazepam—Confusional state—Methotrexate—systemic scleroderma	0.000865	0.00122	CcSEcCtD
Flurazepam—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000858	0.00121	CcSEcCtD
Flurazepam—Feeling abnormal—Prednisone—systemic scleroderma	0.000846	0.00119	CcSEcCtD
Flurazepam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000839	0.00118	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000829	0.00117	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—systemic scleroderma	0.000817	0.00115	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—systemic scleroderma	0.000801	0.00113	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000781	0.0011	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—systemic scleroderma	0.000765	0.00108	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—systemic scleroderma	0.000762	0.00108	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—systemic scleroderma	0.000755	0.00106	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—systemic scleroderma	0.000746	0.00105	CcSEcCtD
Flurazepam—Asthenia—Prednisone—systemic scleroderma	0.000736	0.00104	CcSEcCtD
Flurazepam—Pruritus—Prednisone—systemic scleroderma	0.000726	0.00102	CcSEcCtD
Flurazepam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000707	0.000997	CcSEcCtD
Flurazepam—Diarrhoea—Prednisone—systemic scleroderma	0.000702	0.00099	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000701	0.000989	CcSEcCtD
Flurazepam—Dizziness—Prednisone—systemic scleroderma	0.000679	0.000957	CcSEcCtD
Flurazepam—Vomiting—Prednisone—systemic scleroderma	0.000652	0.00092	CcSEcCtD
Flurazepam—Rash—Prednisone—systemic scleroderma	0.000647	0.000913	CcSEcCtD
Flurazepam—Dermatitis—Prednisone—systemic scleroderma	0.000646	0.000912	CcSEcCtD
Flurazepam—Headache—Prednisone—systemic scleroderma	0.000643	0.000907	CcSEcCtD
Flurazepam—Asthenia—Methotrexate—systemic scleroderma	0.000615	0.000868	CcSEcCtD
Flurazepam—Nausea—Prednisone—systemic scleroderma	0.00061	0.00086	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—systemic scleroderma	0.000607	0.000856	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—systemic scleroderma	0.000587	0.000828	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—systemic scleroderma	0.000567	0.0008	CcSEcCtD
Flurazepam—Vomiting—Methotrexate—systemic scleroderma	0.000545	0.000769	CcSEcCtD
Flurazepam—Rash—Methotrexate—systemic scleroderma	0.000541	0.000763	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—systemic scleroderma	0.00054	0.000762	CcSEcCtD
Flurazepam—Headache—Methotrexate—systemic scleroderma	0.000537	0.000758	CcSEcCtD
Flurazepam—Nausea—Methotrexate—systemic scleroderma	0.000509	0.000719	CcSEcCtD
